Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

Solid Biosciences (SLDB) Return on Assets (2018 - 2024)

Solid Biosciences' Return on Assets history spans 7 years, with the latest figure at 0.47% for Q3 2024.

  • For Q3 2024, Return on Assets rose 10.0% year-over-year to 0.47%; the TTM value through Sep 2024 reached 0.47%, up 10.0%, while the annual FY2023 figure was 0.46%, 4.0% down from the prior year.
  • Return on Assets for Q3 2024 was 0.47% at Solid Biosciences, down from 0.38% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.28% in Q2 2021 and bottomed at 2.01% in Q3 2020.
  • The 5-year median for Return on Assets is 0.46% (2022), against an average of 0.63%.
  • The largest annual shift saw Return on Assets plummeted -106bps in 2020 before it soared 172bps in 2021.
  • A 5-year view of Return on Assets shows it stood at 0.83% in 2020, then soared by 64bps to 0.3% in 2021, then crashed by -55bps to 0.47% in 2022, then decreased by -19bps to 0.56% in 2023, then grew by 16bps to 0.47% in 2024.
  • Per Business Quant, the three most recent readings for SLDB's Return on Assets are 0.47% (Q3 2024), 0.38% (Q2 2024), and 0.44% (Q1 2024).